EGFR and non-small cell lung carcinoma: In this study, the RS-BTIplusVPE model was developed and validated for the early prediction of the response to EGFR-TKI therapy in NSCLC patients with BM, which integrating BTI radiomics features from T1CE, T2W and T2-FLAIR MRI sequences and VPE.